BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2476486)

  • 1. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN; Grossberg SE
    J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative activities.
    Redlich PN; Grossberg SE
    Eur J Immunol; 1990 Sep; 20(9):1933-9. PubMed ID: 1698636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
    Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
    J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
    Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
    Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that distinguish between subspecies of human interferon-alpha and that detect interferon oligomers.
    Shearer M; Taylor-Papadimitriou J; Griffin D; Balkwill F
    J Immunol; 1984 Dec; 133(6):3096-101. PubMed ID: 6491281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
    Reis LF; Le JM; Hirano T; Kishimoto T; Vilcek J
    J Immunol; 1988 Mar; 140(5):1566-70. PubMed ID: 3279118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of four monoclonal antibodies specific for human interferon-alpha-1 and -alpha-2.
    Noll F; Handschack W; Eichmann E; Gaestel M; Schneider F; Kuhl R; Löster K
    Biomed Biochim Acta; 1989; 48(1):165-76. PubMed ID: 2775248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct domains of recombinant human IFN-gamma responsible for anti-viral effector function.
    Alfa MJ; Jay FT
    J Immunol; 1988 Oct; 141(7):2474-9. PubMed ID: 2459212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine monoclonal antibodies against human fibroblast (beta) interferon. Correlation of the neutralization of antiviral and antiproliferative activities.
    Kontsek P; Borecký L; Kontseková E; Novák M
    Acta Virol; 1989 Dec; 33(6):547-52. PubMed ID: 2576596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA.
    Johnson HM; Langford MP; Lakhchaura B; Chan TS; Stanton GJ
    J Immunol; 1982 Dec; 129(6):2357-9. PubMed ID: 6183334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic differentiation between E. coli and CHO cell-derived recombinant and natural human beta-interferons.
    Colby CB; Inoue M; Thompson M; Tan YH
    J Immunol; 1984 Dec; 133(6):3091-5. PubMed ID: 6386981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies neutralizing the antiviral and the antiproliferative activities of human interferon gamma.
    Kontsek P; Borecký L; Kontseková E; Sujanová Z; Novák M
    Acta Virol; 1988 Jul; 32(4):334-8. PubMed ID: 2903638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha.
    Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I
    Immunology; 1991 May; 73(1):8-11. PubMed ID: 1710604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human interleukin-1 beta and their use in a sensitive two-site enzyme linked immunosorbent assay.
    Fontaine S; Damais C; Lando D; Cousin MA
    Lymphokine Res; 1989; 8(2):129-39. PubMed ID: 2471900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hyperthermia on the in vitro antiproliferative activities of HuIFN-alpha, HuIFN-beta, and rHuIFN-gamma employed separately and in combination.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(3):145-54. PubMed ID: 3151143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassay for the quantitation of human leukocyte interferon.
    Berthold W; Merk W; Adolf GR
    Arzneimittelforschung; 1985; 35(1A):364-9. PubMed ID: 4039175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
    Schreiber RD; Hicks LJ; Celada A; Buchmeier NA; Gray PW
    J Immunol; 1985 Mar; 134(3):1609-18. PubMed ID: 2578513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative liquid-phase chemiluminescence ELISA: detection of subtle epitope differences in HuIFN-beta.
    Golgher RR; Redlich PN; Totti DO; Grossberg SE
    J Interferon Cytokine Res; 1999 Sep; 19(9):995-8. PubMed ID: 10505740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
    Exley T; Parti S; Barwick S; Meager A
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.